Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563. (Q43620791)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563. |
scientific article |
Statements
1 reference
Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563. (English)
1 reference
Neuhaus P
1 reference
Langrehr JM
1 reference
Lohmann R
1 reference
Raakow R
1 reference
Jonas S
1 reference
Klupp J
1 reference
Bechstein WO
1 reference
Neuhaus R
1 reference
1 May 2001
1 reference
1 reference
33
1 reference
3
1 reference
2290-2291
1 reference
Identifiers
1 reference
1 reference